Literature DB >> 23975615

Bone flap necrosis after decompressive hemicraniectomy for malignant middle cerebral artery infarction.

Christian Ewald1, Pedro Duenisch, Jan Walter, Theresa Götz, Otto W Witte, Rolf Kalff, Albrecht Günther.   

Abstract

BACKGROUND: Autologous bone flap reinsertion follows as a second surgical intervention after decompressive craniectomy in patients with malignant middle cerebral artery (MCA) infarction. In addition to surgery-related short-term complications, aseptic resorption of the reimplanted bone flap is a possible long-term problem which has not yet been sufficiently elucidated in these patients.
METHODS: A total of 109 patients who had undergone decompressive hemicraniectomy for malignant MCA infarction in our institution between September 1994 and December 2011 were included in the study. Clinical and radiological findings were retrieved retrospectively. Aseptic bone necrosis was classified into two categories based on computer tomographic features.
RESULTS: A total of 76 patients received their own cryoconserved bone flap (mean age 54.34 ± 10.73 years; 49 males). The overall short-term complication rate was 9.2 %. Bone flap necrosis occurred in 26 patients (22.8 %) with 7 flaps showing signs of surgically relevant type II necrosis after a median time of 14 months (interquartile range [IQR] 4-22).
CONCLUSIONS: There is a noticeable complication rate in patients undergoing bone flap reinsertion after hemicraniectomy due to malignant MCA infarction. Aseptic bone necrosis represents a significant complication during long-term follow-up. The pathophysiological mechanisms remain unclear and more efforts should be undertaken to understand and possibly prevent this complication in these patients.

Entities:  

Mesh:

Year:  2014        PMID: 23975615     DOI: 10.1007/s12028-013-9892-4

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  31 in total

1.  The syndrome of the sunken skin flap: a neglected potentially reversible phenomenon affecting recovery after decompressive craniotomy.

Authors:  Arturo Chieregato
Journal:  Intensive Care Med       Date:  2006-08-18       Impact factor: 17.440

2.  Bone flap resorption: risk factors for the development of a long-term complication following cranioplasty after decompressive craniectomy.

Authors:  Patrick Schuss; Hartmut Vatter; Agi Oszvald; Gerhard Marquardt; Lioba Imöhl; Volker Seifert; Erdem Güresir
Journal:  J Neurotrauma       Date:  2013-01-15       Impact factor: 5.269

3.  Post-cranioplasty cerebrospinal fluid hydrodynamic changes: magnetic resonance imaging quantitative analysis.

Authors:  M Dujovny; P Fernandez; N Alperin; W Betz; M Misra; M Mafee
Journal:  Neurol Res       Date:  1997-06       Impact factor: 2.448

4.  Timing of cranioplasty after decompressive craniectomy for ischemic or hemorrhagic stroke.

Authors:  Mark P Piedra; Brian T Ragel; Aclan Dogan; Nicholas D Coppa; Johnny B Delashaw
Journal:  J Neurosurg       Date:  2012-11-09       Impact factor: 5.115

5.  Failure of autologous bone-assisted cranioplasty following decompressive craniectomy in children and adolescents.

Authors:  Gerald A Grant; Matthew Jolley; Richard G Ellenbogen; Theodore S Roberts; Joseph R Gruss; John D Loeser
Journal:  J Neurosurg       Date:  2004-02       Impact factor: 5.115

6.  Long-term outcome of subcutaneously preserved autologous cranioplasty.

Authors:  Alireza Shoakazemi; Thomas Flannery; Robert Scott McConnell
Journal:  Neurosurgery       Date:  2009-09       Impact factor: 4.654

7.  Early combined cranioplasty and programmable shunt in patients with skull bone defects and CSF-circulation disorders.

Authors:  Mario N Carvi Y Nievas; Hans-Georg Höllerhage
Journal:  Neurol Res       Date:  2006-03       Impact factor: 2.448

8.  Syndrome of the trephined.

Authors:  Vivek Joseph; Peter Reilly
Journal:  J Neurosurg       Date:  2009-10       Impact factor: 5.115

9.  Neurological recovery after cranioplasty.

Authors:  D H Segal; J S Oppenheim; J A Murovic
Journal:  Neurosurgery       Date:  1994-04       Impact factor: 4.654

10.  [Cranioplasty following decompressive craniectomy--analysis of 300 cases (author's transl)].

Authors:  A Yamaura; M Sato; K Meguro; T Nakamura; K Uemura
Journal:  No Shinkei Geka       Date:  1977-04
View more
  7 in total

Review 1.  The storage of skull bone flaps for autologous cranioplasty: literature review.

Authors:  Vicente Mirabet; Daniel García; Nuria Yagüe; Luis Roberto Larrea; Cristina Arbona; Carlos Botella
Journal:  Cell Tissue Bank       Date:  2021-01-09       Impact factor: 1.522

Review 2.  Complications Associated with Decompressive Craniectomy: A Systematic Review.

Authors:  David B Kurland; Ariana Khaladj-Ghom; Jesse A Stokum; Brianna Carusillo; Jason K Karimy; Volodymyr Gerzanich; Juan Sahuquillo; J Marc Simard
Journal:  Neurocrit Care       Date:  2015-10       Impact factor: 3.210

3.  Decompressive Hemicraniectomy in the Age of Personalized Medicine.

Authors:  Michael N Diringer
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

Review 4.  Malignant MCA Stroke: an Update on Surgical Decompression and Future Directions.

Authors:  Carolina B Maciel; Kevin N Sheth
Journal:  Curr Atheroscler Rep       Date:  2015-07       Impact factor: 5.113

5.  Efficacy and safety of durotomy after decompressive hemicraniectomy in traumatic brain injury.

Authors:  R B Moringlane; N Keric; F B Freimann; D Mielke; R Burger; D Duncker; V Rohde; K L V Eckardstein
Journal:  Neurosurg Rev       Date:  2017-02-09       Impact factor: 3.042

Review 6.  A systematic review and meta-analysis of factors involved in bone flap resorption after decompressive craniectomy.

Authors:  Francesco Signorelli; Martina Giordano; Valerio Maria Caccavella; Eleonora Ioannoni; Camilla Gelormini; Anselmo Caricato; Alessandro Olivi; Nicola Montano
Journal:  Neurosurg Rev       Date:  2022-01-21       Impact factor: 3.042

7.  Aseptic bone-flap resorption after cranioplasty - incidence and risk factors.

Authors:  Ali Rashidi; I Erol Sandalcioglu; Michael Luchtmann
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.